Somatostatin Receptor Subtype 2 Expression and Somatostatin Receptor Scintigraphy Positivity in Pancreatic Serous Cystadenomas

被引：6
|
作者：
Pote, Nicolas [1 ,2 ]
Lebtahi, Rachida [2 ,3 ]
Hentic, Olivia [4 ]
Speisky, Daniela [1 ]
Sauvanet, Alain [2 ,5 ]
Vullierme, Marie-Pierre [6 ]
Bedossa, Pierre [1 ,2 ]
Ruszniewski, Philippe [2 ,4 ]
Couvelard, Anne [2 ,7 ]
机构：
[1] Hop Beaujon, AP HP, DHU UNITY, Dept Pathol, Clichy, France
[2] Univ Paris Diderot, Sorbonne Paris Cite, Paris, France
[3] Hop Beaujon, AP HP, DHU UNITY, Dept Nucl Med, Clichy, France
[4] Hop Beaujon, AP HP, DHU UNITY, Dept Gastroenterol Pancreatol, Clichy, France
[5] Hop Beaujon, AP HP, DHU UNITY, Dept Chirurg Pancreaticobiliaire & Hepat, Clichy, France
[6] Hop Beaujon, AP HP, DHU UNITY, Dept Radiol, Clichy, France
[7] Hop Bichat Claude Bernard, AP HP, DHU UNITY, Dept Pathol, F-75877 Paris, France
来源：
PANCREAS | 2015年 / 44卷 / 04期
关键词：
TUMORS; MANAGEMENT; NEOPLASMS;
D O I：
10.1097/MPA.0000000000000319
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：672 / 674
页数：3
相关论文
共 50 条
  • [1] Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2
    John, M
    Meyerhof, W
    Richter, D
    Waser, B
    Schaer, JC
    Scherubl, H
    BoeseLandgraf, J
    Neuhaus, P
    Ziske, C
    Molling, K
    Riecken, EO
    Reubi, JC
    Wiedenmann, B
    [J]. GUT, 1996, 38 (01) : 33 - 39
  • [2] Evaluation of Somatostatin and Dopamine Receptor Subtype 2 Expression in Pancreatic Neuroendocrine Neoplasms
    Lee, L.
    Ito, T.
    Kawabe, K.
    Otsuka, T.
    Nakamura, M.
    Oda, Y.
    Ogawa, Y.
    [J]. NEUROENDOCRINOLOGY, 2017, 105 : 11 - 11
  • [3] Alteration of somatostatin receptor subtype 2 gene expression in pancreatic tumor angiogenesis
    Manoj Kumar Gupta
    [J]. World Journal of Gastroenterology, 2004, (01) : 132 - 135
  • [4] Alteration of somatostatin receptor subtype 2 gene expression in pancreatic tumor angiogenesis
    Qin, RY
    Fang, RL
    Gupta, MK
    Liu, ZR
    Wang, DY
    Chang, Q
    Chen, YB
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2004, 10 (01) : 132 - 135
  • [5] Coexpression of somatostatin receptor subtype 5 affects internalization and trafficking of somatostatin receptor subtype 2
    Sharif, Nadder
    Gendron, Louis
    Wowchuk, Julia
    Sarret, Philippe
    Mazella, Jean
    Beaudet, Alain
    Stroh, Thomas
    [J]. ENDOCRINOLOGY, 2007, 148 (05) : 2095 - 2105
  • [6] Somatostatin receptor subtype expression in pancreatic cancer in vitro and in vivo.
    Raderer, M
    Hamilton, G
    Pangerl, T
    Haberl, I
    Kornek, G
    Hejna, M
    Kurtaran, A
    Virgolini, I
    Scheithauer, W
    [J]. BRITISH JOURNAL OF CANCER, 1999, 80 : 96 - 96
  • [7] Somatostatin receptor subtype expression in pancreatic cancer in vitro and in vivo.
    Raderer, M
    Pangerl, T
    Hamilton, G
    Kornek, G
    Hejna, M
    Kurtaran, A
    Scheithauer, W
    Virgolini, I
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 1026 - 1026
  • [8] Expression of somatostatin receptor subtype 2 and subtype 5 in thyroid malignancies
    Woelfl, S.
    Bogner, S.
    Huber, H.
    Salaheddin-Nassr, S.
    Hatzl, M.
    Decristoforo, C.
    Virgolini, I.
    Gabriel, M.
    [J]. NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2014, 53 (05): : 179 - 185
  • [9] Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma
    Mato, E
    Matías-Guiu, X
    Chico, A
    Webb, SM
    Cabezas, R
    Berná, L
    De Leiva, A
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (07): : 2417 - 2420
  • [10] Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2 and 5' (vol 38, pg 33, 1996)
    John, M
    [J]. GUT, 1996, 38 (02) : 302 - 302
12345